For instance, the serum TGF-β1 concentration is correlated with the degree of liver fibrosis in CHC patients, and serum TGF-β1 levels are reduced in CHC patients who respond to interferon therapy and are associated with the regression of liver fibrosis12, 32. Here, TGFB1 is linked to Hepatic fibrosis.